| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 90130276 | FILING DATE | 08/21/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MUNN LEWIS, LAKEISHA S |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
| RUN DATE | 06/25/2021 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 06/24/2021 | ||
| LITERAL MARK ELEMENT | RESOLUTION | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | YES | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | RESOLUTION |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Resolution Therapeutics Limited |
| ADDRESS | 8 Bloomsbury Street London, WC1B3SR |
| ENTITY | 99-private limited company |
| CITIZENSHIP | United Kingdom |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Chemicals preparations for scientific purposes; chemicals for use in research; chemicals, enzymes, DNA and RNA for research use; cells for scientific purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use; biological preparations for cell therapy |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, ophthalmological conditions, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment of hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, ophthalmological conditions, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents for medical use; cells for medical or veterinary use; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; pharmaceutical and biopharmaceutical preparations of cells from humans or animals which have been adapted for medical or therapeutic purposes |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION TEXT | Treatment and processing of biological materials; custom manufacture of therapeutic drugs, namely, custom manufacture of cells and cell therapies |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services and research and design relating thereto, namely, scientific research in the field of in the fields of haematology, immunology, neurology, respiratory diseases, ophthalmology, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services, in the field of cell therapies and gene therapies; chemical and biological analysis and research services; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services, namely, manipulation of human and animal cells for therapeutic purposes ; advisory and consultancy relating to all the aforesaid services |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical and veterinary research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of extraction of human and animal cells from patients; medical services, namely, reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 040 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON United Kingdom |
| APPLICATION NO. | N/A |
| APPLICATION FILING DATE | 08/21/2020 |
| FOREIGN REG NO. | N/A |
| FOREIGN REG DATE | N/A |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | N/A |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 06/24/2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 06/24/2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 06/24/2021 | ALIE | A | ASSIGNED TO LIE | 008 |
| 04/14/2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 12/21/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 12/21/2020 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 12/21/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 12/17/2020 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 09/24/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 08/25/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Rebecca Liebowitz |
| CORRESPONDENCE ADDRESS | Rebecca Liebowitz VENABLE LLP P.O. BOX 34385 WASHINGTON, DC 20043 |
| DOMESTIC REPRESENTATIVE | Rebecca Liebowitz |